載入中
NASDAQHealthcareMedical - Specialties
最新資料
US$127.51
+US$1.45 · +1.15%
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
前收盤價
US$127.51
+US$1.45 · +1.15%
盤中時間採用ET。市場資料可能有所延遲。
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
日內區間
目前US$127.51
52週區間
目前US$127.51
盤中時間採用ET。市場資料可能有所延遲。
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
日內區間
目前US$127.51
52週區間
目前US$127.51
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2026會計年度 | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 |
|---|---|---|---|---|---|
| 營收 | 2.49億 USD | 2.41億 USD | 2.16億 USD | 2.19億 USD | 1.84億 USD |
| 銷貨成本 | 9086萬 USD | 9010.8萬 USD | 8293.7萬 USD | 8538.7萬 USD | 7524.5萬 USD |
| 毛利 | 1.58億 USD | 1.51億 USD | 1.33億 USD | 1.34億 USD | 1.09億 USD |
| 研究與開發 | 2030.8萬 USD | 1951.8萬 USD | 1930萬 USD | 2049萬 USD | 1576.7萬 USD |
| 銷售、一般及管理費用 | 1.19億 USD | 1.15億 USD | 1.11億 USD | 1.1億 USD | 8862.1萬 USD |
| 營業費用 | 1.4億 USD | 1.35億 USD | 4.05億 USD | 1.3億 USD | 1.04億 USD |
| 利息支出 | 1069.2萬 USD | 1185.9萬 USD | 569.7萬 USD | 477萬 USD | 388.5萬 USD |
| 折舊和攤銷 | 2327.1萬 USD | 2452.7萬 USD | 3157.4萬 USD | 3313.4萬 USD | 2506.8萬 USD |
| 營業利益 | 1851.1萬 USD | 1633.6萬 USD | −2.72億 USD | 332萬 USD | 470.2萬 USD |
| 淨利 | 671.2萬 USD | −197.4萬 USD | −2.54億 USD | 93萬 USD | 187.1萬 USD |
公司資料更新於 2026年10月11日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$110
下跌空間 13.73%年度分割調整後的每股現金分配。
US$0.64
2025年（完整年度）0.0% 自從 2021
2026年（部分年度）：US$0.48
US$0.64
2,021
US$0.64
2,022
US$0.64
2,023
US$0.64
2,024
US$0.64
2,025
US$0.48
2,026*
* 在現有股息歷史記錄中，該日曆年僅包含部分期間。
| 行動 | 除息日 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2026年8月31日 | US$0.16Quarterly | 2026年8月31日 | 2026年9月15日 |
股息 | 2026年5月29日 | US$0.16Quarterly | 2026年5月29日 | 2026年6月15日 |
股息 | 2026年2月27日 | US$0.16Quarterly | 2026年2月28日 | 2026年3月16日 |
股息 | 2025年11月28日 | US$0.16Quarterly | 2025年11月28日 | 2025年12月15日 |
股息 | 2025年8月29日 | US$0.16Quarterly | 2025年8月29日 | 2025年9月15日 |
股息 | 2025年5月30日 | US$0.16Quarterly | 2025年5月30日 | 2025年6月16日 |
除息 2026年8月31日
US$0.16
Quarterly
2026年8月31日登記 · 支付日 2026年9月15日
除息 2026年5月29日
US$0.16
Quarterly
2026年5月29日登記 · 支付日 2026年6月15日
除息 2026年2月27日
US$0.16
Quarterly
2026年2月28日登記 · 支付日 2026年3月16日
除息 2025年11月28日
US$0.16
Quarterly
2025年11月28日登記 · 支付日 2025年12月15日
除息 2025年8月29日
US$0.16
Quarterly
2025年8月29日登記 · 支付日 2025年9月15日
除息 2025年5月30日
US$0.16
Quarterly
2025年5月30日登記 · 支付日 2025年6月16日
報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI2154.75萬0.00%2.3兆 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM1817.18萬0.02%787.4億 USD0.19%US$278.94+0.49%
Keeley Dividend ETFKDVD1777.76萬2.22%800萬 USD0.90%US$27.7170.00%
Vanguard Extended Market ETFVXF819.8萬0.01%954億 USD0.05%US$235+0.80%
Fidelity Enhanced Small Cap ETFFESM683.03萬0.10%64.1億 USD0.28%US$45.46+0.46%
iShares Russell 2000 Growth ETFIWO630.96萬0.05%139.17億 USD0.24%US$356.78+0.94%
Dimensional - US Targeted Value ETFDFAT535.89萬0.02%301.22億 USD0.33%US$67.27-0.43%
Dimensional - US Small Cap ETFDFAS462.1萬0.01%338.69億 USD0.31%US$78.35+0.32%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMKeeley Dividend ETFKDVDVanguard Extended Market ETFVXFFidelity Enhanced Small Cap ETFFESMiShares Russell 2000 Growth ETFIWODimensional - US Targeted Value ETFDFATDimensional - US Small Cap ETFDFASAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
